Investing News NetworkYour trusted source for investing success

Videos
Companies
Press Releases
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Private Placements
Trending
Trending Articles

Could the Silver Price Really Hit US$100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Top 10 Countries for Natural Gas Production (Updated 2024)

Where Does Tesla Get its Lithium? (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies

Top 10 Copper-producing Companies (Updated 2024)

7 Biggest Lithium-mining Companies

Copper Price Update: Q1 2024 in Review

A State-by-State Guide to Cannabis in Australia

Trending Press Releases

European Lithium to Acquire Leinster Lithium Project in Ireland with CRML Shares

Energy Fuels Announces Agreement for Transformational Acquisition of Base Resources, Creating a Global Leader in Critical Minerals Production with a Focus on Uranium, Rare Earth Elements and Heavy Mineral Sands

SOURCE ROCK ROYALTIES ANNOUNCES 2023 RESULTS INCLUDING RECORD ANNUAL & QUARTERLY FUNDS FROM OPERATIONS

Freegold Announces Start of 2024 Drilling Program at Golden Summit

Galan Signs Pivotal Commercial Agreement with Catamarca Government to Commercialise Lithium Chloride Concentrate

Acquisition of Bengal Mining - Highly Prospective Lithium Projects in Brazil’s Lithium Valley

More Press Releases
Trending Companies

Galan Lithium

GLN:AU

International Graphite

IG6:AU

Cardiex Limited

CDX:AU

CVD Equipment Corporation

CVV:US
More Companies
Trending Reports

Lithium Outlook for Australia

2024 Gold Outlook Report

2024 Copper Market Outlook (Australia Ed.)

2024 Lithium Market Outlook

More Outlook Reports
Resource
Resource
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Tech
Tech
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Life Science
Life Science
Popular Lists
Investing Ideas
Outlook Reports
Investing Guides
Gold
Copper
Uranium
Oil and Gas
Artificial Intelligence
Biotech
loader

Clene Inc.

NASDAQ:CLNN
Press Releases

Clene Announces Closing of $5 Million Debt Facility from the State of Maryland

VISIONARY-MS Trial Results Featured in Platform Presentation at PACTRIMS 2022: CNM-Au8® Demonstrated Global Neurological Improvement in Stable MS Patients as Adjunct to Background Disease Modifying Therapies

Clene Reports Third Quarter 2022 Financial Results and Recent Operating Highlights

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).

×